(N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+) Summary

7 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Key Diseases for which (N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+) is Relevant

1. Diarrhea : 3 results
   
2. Neoplasms (Cancer) : 1 result
   
3. Lung Neoplasms (Lung Cancer) : 1 result
   
4. Contagious Ecthyma (Orf) : 1 result
   
5. DNA Damage : 1 result
   

Drugs Related to (N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+)

1. DNA (Deoxyribonucleic Acid)
2. 1-amidino-3-(3-sulfamoylphenyl)urea
3. Virulence Factors (Pathogenicity Factors)
4. Bleomycin (Blenoxane)
5. Amsacrine (AMSA)

Therapies Related to (N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+)